Morgenesis LLC, the US point of care (POCare) services subsidiary of global cell and gene therapies developer biotech Orgenesis, has signed an agreement with contract development and manufacturing organisation SCTbio to open new POCare sites within the Czech Republic. Click to read more.
Orgenesis announces collaboration agreement with SCTbio to expand POCare sites in the Czech Republic and enhance capabilities for the production of lentivirus vectors Germantown, Maryland, US and Prague, Czech Republic – May 18, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis”), a glob.
Orgenesis Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus Vectors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.